Clinical Trial Update: Sulforaphane Use to Effect Inflammatory and Metabolic Changes in Virally Suppressed HIV Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating sulforaphane to modulate inflammatory and metabolic changes in virally suppressed HIV patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Sulforaphane (sulforaphane)

Snippet

Sponsor: Sunshine Specialty Health Care | Conditions: HIV Infections | Phase 4 | Status: UNKNOWN